Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors. | World J Clin Oncol | 2023 | 37009528 | PubTator, text mining | PubMed |
| PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy. | Mol Cancer | 2023 | 36991452 | PubTator, text mining | PubMed |
| Structure Determination of Challenging Protein-Peptide Complexes Combining NMR Chemical Shift Data and Molecular Dynamics Simulations. | J Chem Inf Model | 2023 | 36988562 | PubTator, text mining | PubMed |
| Cereblon-Recruiting PROTACs: Will New Drugs Have to Face Old Challenges? | Pharmaceutics | 2023 | 36986673 | PubTator, text mining | PubMed |
| Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids. | Int J Mol Sci | 2023 | 36982852 | PubTator, text mining | PubMed |
| Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy. | Int J Mol Sci | 2023 | 36982740 | PubTator, text mining | PubMed |
| VPg Impact on Ryegrass Mottle Virus Serine-like 3C Protease Proteolysis and Structure. | Int J Mol Sci | 2023 | 36982419 | PubTator, text mining | PubMed |
| Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022. | Int J Mol Sci | 2023 | 36982263 | PubTator, text mining | PubMed |
| New Approaches to Targeting Epigenetic Regulation in Bladder Cancer. | Cancers (Basel) | 2023 | 36980741 | PubTator, text mining | PubMed |
| Bromodomain and Extra-Terminal Proteins in Brain Physiology and Pathology: BET-ing on Epigenetic Regulation. | Biomedicines | 2023 | 36979729 | PubTator, text mining | PubMed |
| Epigenetic and Drug Response Modulation of Epigalocaten-In-3-Gallate in Staphylococcus aureus with Divergent Resistance Phenotypes. | Antibiotics (Basel) | 2023 | 36978386 | PubTator, text mining | PubMed |
| Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. | J Transl Med | 2023 | 36973787 | PubTator, text mining | PubMed |
| Genome-wide analysis of bromodomain gene family in Arabidopsis and rice. | Front Plant Sci | 2023 | 36968369 | PubTator, text mining | PubMed |
| The effects of MYC on tumor immunity and immunotherapy. | Cell Death Discov | 2023 | 36966168 | PubTator, text mining | PubMed |
| Targeted Protein Degradation through E2 Recruitment. | ACS Chem Biol | 2023 | 36940189 | PubTator, text mining | PubMed |
| Clinicopathological features and prognostic outcomes of molecularly defined entities in the new edition of the WHO classification of sinonasal carcinoma. | Front Oncol | 2023 | 36937407 | PubTator, text mining | PubMed |
| Sinonasal NUT carcinoma: A retrospective case series from a single institution. | Front Surg | 2023 | 36936659 | PubTator, text mining | PubMed |
| High Expression Level of BRD4 Is Associated with a Poor Prognosis and Immune Infiltration in Esophageal Squamous Cell Carcinoma. | Dig Dis Sci | 2023 | 36933111 | PubTator, text mining | PubMed |
| Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation. | Mol Ther Nucleic Acids | 2023 | 36923952 | PubTator, text mining | PubMed |
| The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors. | Int J Biol Sci | 2023 | 36923930 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=14